Author

Ying-Xian Pan

Rutgers, The State University of New Jersey

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Bryan L Roth· 1 shared Catarina Guimarães‐TeixeiraiD· 1 shared Gavril Pasternak· 1 shared Hui Xian PohiD· 1 shared Jianheng Fox LiuiD· 1 shared Jin XuiD· 1 shared Louise V. B. NicholsoniD· 1 shared Michael Bauman· 1 shared

Activity by Year

2017-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Bryan L Roth

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

FTO does not function as an m6A eraser in AML: a reassessment using direct RNA nanopore sequencing

Louise V. B. Nicholson, Catarina Guimarães‐Teixeira, Jianheng Fox Liu, Raymond Chien, Jin Xu, Hui Xian Poh, Ying-Xian Pan, Samie R. Jaffrey

This study reassesses FTO's role as an m6A eraser in AML using direct RNA nanopore sequencing, finding no effect on m6A stoichiometry but increased m6Am levels.

bioRxiv · Oct 22, 2025 · PreprintMolecular Biology

PHARMACOLOGY OF W-18 AND W-15

Xi-Ping Huang, Tao Che, Thomas Mangano, Valerie Le Rouzic, Ying-Xian Pan, Susruta Majumdar, Michael Cameron, Michael Bauman, Gavril Pasternak, Bryan L Roth

This study investigates the pharmacological profiles of W-18 and W-15, finding no significant opioid activity or other psychoactive drug target interactions.

JCI Insight · Nov 16, 2017Peer-reviewedNeuroscience